Call for Abstract

8th World Congress on Molecular Pathology, will be organized around the theme “Shaping the Future for Innovations in Molecular Pathology”

Molecular Pathology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Molecular Pathology 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Molecular pathology is an evolving discipline in the field of pathology which is determined in the study and inference of infirmity by examining the macromolecules within cells, tissues, organs, or bodily fluids. A diverse range of methods are used in molecular pathology including Genomics, Proteomics, Biochemistry and several Analytical techniques. It is a scientific discipline that covers the improvement of molecular and genetic approaches to the judgement and classification of human diseases, the design and development of analytical biomarkers for diagnosis response and disease advancement and the vulnerability of individuals of different genetic composition to develop disorders. A key reflection is that more precise treatment is possible when the diagnosis is based on the molecular changes at the genetic level in diseases like cancer.       

  • Track 1-1Integrated diseases management strategies
  • Track 1-2 Microvascular neuropathology
  • Track 1-3Molecular pathology in other neurological disorders
  • Track 1-4 Molecular biology in molecular pathology
  • Track 1-5 Genetics in molecular pathology
  • Track 1-6 Proteomics in molecular pathology
  • Track 1-7Biochemistry in molecular pathology
  • Track 1-8Molecular diseases

Molecular genetics is the discipline of biology and genetics which deals with the study of the function and structure of genes at the macromolecular level. It employs the techniques of genetics to reveal the behaviour of molecules and the interactions among them. Increasing innovations in the field of molecular pathology are engaging efforts for the advancements of molecular genetic techniques in diagnosing diseases. Along with shaping the pattern of progenies, molecular genetics improves the knowledge of developmental biology and mutations that are responsible for certain types of diseases. Implementing the molecular genetic techniques in pathology helps to understand the basic cause of the mutation in the genome which is leading to a disorder in the body.

  • Track 2-1Gene therapy in molecular pathology
  • Track 2-2Genetic/epigenetic alterations of human neoplasms
  • Track 2-3DNA, RNA, Protein Isolation
  • Track 2-4Quantification of molecules
  • Track 2-5Human Genome Project

Emerging diseases and the continuing change in their behaviour is creating global challenges in healthcare. Innovations in molecular diagnostics techniques have delivered us with the improved indulgent of molecular processes affecting human health, and diseases. The tools derived thereof are becoming the regular treatment care for several diseases. The accessibility of new sequencing methods, microarrays, microfluidics, biosensors, and biomarker assays has influenced the research towards developing diagnostic platforms. Molecular Pathology deals with different genetic and proteomic level techniques to identify and diagnose diseases.

  • Track 3-1In situ Hybridization in molecular diagnosis
  • Track 3-2Mass Spectrometry in molecular diagnosis
  • Track 3-3DNA sequencing in molecular diagnosis
  • Track 3-4Electrophoresis in molecular diagnosis
  • Track 3-5Chromatography in molecular diagnosis
  • Track 3-6Polymerase Chain Reaction in molecular diagnosis
  • Track 3-7Immunohistochemistry in molecular diagnosis
  • Track 3-8Immunocytochemistry in molecular diagnosis

DNA sequencing is the tool for determining the particular arrangement of nucleotides within a DNA molecule. It includes any process or technique that is used to determine the order of the four bases i.e. adenine, guanine, cytosine, and thymine, in a DNA strand. The arrangement is very much specific and varies from individual to individual. The introduction of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. With increase in research in sequencing the demand for revolutionary technologies that deliver fast, economical and precise genome information has been increased. This challenge has catalysed the improvement of next-generation sequencing (NGS) technologies. By virtue of sequencing clonally amplified DNA templates or single DNA molecules in an immensely parallel approach in a flow cell, NGS delivers both qualitative and quantitative sequence data. However NGS is powerful and can be intended to have multiple applications in clinical diagnostics and molecular pathology.

  • Track 4-1NGS resources for pathologists
  • Track 4-2Next generation sequencing to cancer diagnostics
  • Track 4-3Molecular diagnosis of infectious diseases through NGS
  • Track 4-4Different NGS tools in molecular pathology
  • Track 4-5Characterization of pathogen through NGS
  • Track 4-6Gene expression mapping of diseases through NGS
  • Track 4-7Determining pathway for drug resistant disease traits through NGS

Molecular Biomarkers plays an important role in biological characteristic which can be any molecular, chemical or physiologic change which had made these markers a companion diagnostics. These are small fragments of macromolecules which are used to detect gene expressions before or after disease state. Molecular Biomarker is a representative diagnostic tool that is quantitatively measured and estimated as an indicator of regular biological progressions, pathogenic developments or pharmacological responses to a therapeutic intercession. Biomarkers can be molecules, or genes, gene products, enzymes, or hormones to quantify the degree of disease condition. Biomarkers are the methods used to achieve a clinical valuation in case of diagnosis. They examine health condition in individuals through populations so that suitable therapeutic mediation can be planned. In the present situation more than a thousands of organization and universities have donated to the field of Biomarkers investigation particularly molecular and cancer biomarkers.

  • Track 5-1Protein biomarkers
  • Track 5-2Genetic testing of molecular biomarkers
  • Track 5-3Biomarker and pharmacology
  • Track 5-4Tissue microarrays
  • Track 5-5Advances in biomarker application
  • Track 5-6Clinical biomarkers
  • Track 5-7Cancer biomarkers
  • Track 5-8Nucleic acid based biomarkers
  • Track 5-9Lipid biomarkers
  • Track 5-10Autism biomarkers

The discovery of germline and somatic mutations present in different cancers existed due to the recent advances in genomic studies. Treatments and therapies selected for cancer patients are no longer based on histopathological techniques for analysing tumors. The role of pathologists in using these molecular techniques in diagnosis and the availability of laboratories to perform these tests had lead cancer treatment to a new level. It includes novel techniques and methods for treatment of different Cancer, targeted therapy, delivery methods for on going molecular tests to patients. These improvements conveyed about a standard shift in the way we define cancer and in our information of cancer biology. In the late 19th and early 20th centuries, cancer was defined by the demonstration of incursion and metastases based on unsophisticated discoveries at surgery or dissection. Expansions in molecular pathology during the 20th century empowered more accurate perceptions to progress and be implemented in clinical practice.

  • Track 6-1Advances in cancer pathology
  • Track 6-2Molecular pathology in lung cancer
  • Track 6-3Molecular pathology in breast cancer
  • Track 6-4Molecular pathology in colorectal cancer
  • Track 6-5Molecular pathology in gastric cancer
  • Track 6-6Molecular pathology in prostate cancer
  • Track 6-7Molecular pathology in skin cancer
  • Track 6-8Tumor pathology
  • Track 6-9Molecular diagnosis of other cancer

Neurological disorder is any syndrome of the body nervous system. Any type of physical, biochemical or electrical anomalies in the brain, spinal cord or other nerves can result in a range of symptoms causing a neurological disorder. Syndromes of the central nervous system endure amongst the supreme captivating maladies identified to humanity. This is because neurological disorders are characteristically distressing to affected patients and their families, often entities of the potentials that we most intensely associate with being human, and since the massive number of neurological disorders lack effective treatments the need of advancement in this field is needed. Molecular pathology techniques provide a pathway to recover human kind from these disorders. The introduction of molecular genetics methodologies to map and identify disease genes laid the basis for an extraordinary improvement in our understanding of the pathogenic origin of abundant neurological disorders.

  • Track 7-1Molecular pathology of hereditary neurological disorders
  • Track 7-2Molecular diagnosis for astrocyte dysfunction in neurological disorders
  • Track 7-3NGS for molecular diagnosis of neurological disorders
  • Track 7-4Molecular diagnosis of Alzheimer’s disease
  • Track 7-5Molecular diagnosis of frontotemporal dementia
  • Track 7-6Molecular diagnosis of paraneoplastic neurological syndromes

Cardiology is a branch of medicine which deals with syndromes of the heart. The field contains molecular diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, heart valve disease and electrophysiology. Molecular Cardiology aims to expand our knowledge for the improvement of diagnosis of cardiovascular diseases. Rapid developments in molecular cardiology in the past decade have transformed the exercise of clinical cardiology by emphasizing the in depth knowledge for molecular mechanisms of cardiovascular diseases, and providing novel diagnostic and therapeutic methods. It is estimated that information in molecular cardiology will increase exponentially in the coming period. Already, molecular and genetic cardiology has improved attentiveness of the inheritance of defective genes and their impact on cardiovascular diseases.

  • Track 8-1Molecular diagnosis of cardiac amyloidosis
  • Track 8-2Molecular diagnosis of congenital heart diseases
  • Track 8-3Molecular diagnosis for myocardium disorder
  • Track 8-4Molecular diagnosis for pericardium disorder
  • Track 8-5Molecular diagnosis for heart valve disorder

Conventionally, the clinical medicinal microbiology laboratories have functioned to detect the etiologic causes of infectious diseases performing the direct analysis and culture of experimental specimens. Direct examination is restricted by the quantity of microorganisms available and by the capability of the laboratories to effectively distinguish the pathogen. Over the past several years, the improvement and application of molecular diagnostic tools has originated a revolution in the diagnostic measures and monitoring of infectious diseases. The extensive sensitivity and diversity of many molecular technologies permit the precise detection of very small numbers of microorganisms. Microbial phenotypic characteristics, such as protein, bacteriophage, and chromatographic profiles, as well as biotyping and susceptibility testing, are used in most routine laboratories for identification and differentiation.

  • Track 9-1Molecular techniques for diagnosing infectious diseases
  • Track 9-2Molecular diagnosis of infectious diseases by nucleic acid hybridization
  • Track 9-3Molecular diagnosis of infectious diseases by plasmid profiling
  • Track 9-4Molecular diagnosis of infectious diseases by RFLP
  • Track 9-5Molecular diagnosis of infectious diseases by PCR
  • Track 9-6Molecular epidemiology and infection control
  • Track 9-7Molecular diagnosis of mycobacteria
  • Track 9-8Diagnosis of infectious diseases using other molecular techniques

The use of molecular tests for the diagnosis of viral infections is increasing, because of the improved sensitivity and fast result providing capability of these tests. A diversity of molecular techniques is now available for the identification and quantification of viral pathogens. Molecular diagnostic tools for viral testing have investigated a rapid improvement during the last years and have been introduced in the majority of laboratories as a new way for the diagnosis of human pathogens like HIV, HPV, Zika Virus etc. These molecular techniques has reduced the use of other techniques such as viral culture based methods and serological assays in the clinical virology laboratory. Amplified and non-amplified nucleic acid techniques, PCR based techniques, microarrays, target amplification techniques are some of the advanced molecular techniques used for diagnosing viral infection.

  • Track 10-1Molecular techniques for identification of virus
  • Track 10-2Molecular diagnosis of viral respiratory disease
  • Track 10-3Molecular diagnosis for viral infection in the nervous system
  • Track 10-4Molecular diagnosis for gastrointestinal virus
  • Track 10-5Molecular diagnosis for viral skin infection
  • Track 10-6Molecular diagnosis for foodborne viral infection
  • Track 10-7Molecular diagnosis for sexually transmitted viral infections
  • Track 10-8Molecular diagnosis for other viral infection
  • Track 10-9Zika Virus Infection

Immune deficiency disorders are a group of diseases related with a genetic inclination to persistent infections, distortion, autoimmunity and allergy. The molecular base of numerous of these syndromes has been acknowledged in the last two decades. Most of these immunological disorders are inherited as a single gene defects. Classifying the original genetic defect plays a critical part in patient supervision together with diagnosis, predictive information, prenatal diagnosis and is valuable in describing new diseases. The clinical effectiveness of these molecular diagnostic tests offers an extensive variety of treatment and vaccine development. Several molecular tests are performed for diagnosing immunological disorders which are gene therapy, nucleic acid amplification based methods, use of DNA probes and other hybridization methods.

  • Track 11-1Molecular diagnosis for autoimmune disorders
  • Track 11-2Molecular diagnosis for primary immunodeficiency disorders
  • Track 11-3Molecular diagnosis for secondary immunodeficiency disorders
  • Track 11-4Molecular diagnosis for immunodeficiency disorders causing allergy
  • Track 11-5Molecular techniques for vaccine development

Molecular pathology deals with tools and techniques that can significantly improve the drug discovery and development methods which help to make the possibilities of personalized medicine a reality. Molecular Pathology in drug discovery and development offers an incomparable guide to this leading-edge discipline and its applications to pharmaceutical science. With assistances from foremost illuminations in drug discovery, drug development, and molecular pathology, this field compromises the methods that are applied to the progression of drug discovery and development. The effectual and operative improvement of new targeted drugs will involve more comprehensive molecular arrangements of histologically homogeneous diseases that show heterogeneous clinical outcomes, which can be gained using molecular techniques in drug development.

  • Track 12-1Molecular pathology in oncology target and drug discovery
  • Track 12-2Molecular pathology and transcriptional profiling in early drug development
  • Track 12-3Molecular pathology in nonclinical safety assessment
  • Track 12-4Molecular pathology in development of antibacterial drugs

Molecular profiling deals with the identification and documentation of the structure of a specific DNA, RNA, or protein molecule, generally for the purpose of diagnosing biochemical and genetic disorders. The overall examination of gene and protein expression profiles at the genomic, transcriptomic and proteomic levels is an evolving encouraging tool for novel diagnosis techniques. The accomplishment of the Human Genome Project, prompt developments in bioinformatics, the application of innovative tools like mass spectroscopy and array analysis which allows instantaneous high throughput investigation of thousands of molecules and occurrence of new treatment options like targeted therapy, compelled the confinement of universal exploration permits for a supplementary comprehensive indulgent of the malignant process.

  • Track 13-1Molecular profiling in cancer diagnosis
  • Track 13-2Molecular profiling in genetic disorders
  • Track 13-3Molecular profiling in mutational disorders
  • Track 13-4Molecular profiling through genomic approach
  • Track 13-5Molecular profiling through transcriptomic approach
  • Track 13-6Molecular profiling through proteomic approach
  • Track 13-7Advances in molecular profiling
  • Track 13-8Molecular profiling in drug development

Molecular imaging is a type of medical imaging that offers complete depictions of what is happening inside the body at the molecular and cellular level. Wherever other analytical imaging processes such as x-rays, computed tomography and ultrasound, offer images of physical arrangement, molecular imaging permits physicians to perceive how the body is working and to measure its chemical and biological progressions. Molecular imaging comprises the discipline of nuclear medicine, which utilises very slight quantities of radioactive constituents to detect and diagnose disease. Molecular imaging studies help physicians to regulate the magnitude or severity of the disease, comprising whether it has spread to the other part of the disease and to choose the most operational treatment based on the exceptional biologic features of the patient and the molecular properties of other disease.

  • Track 14-1Molecular imaging in drug development
  • Track 14-2Molecular imaging in cancer diagnosis
  • Track 14-3Molecular imaging in brain disorders
  • Track 14-4Molecular imaging in genetic disorders
  • Track 14-5Molecular imaging in mutational disorders
  • Track 14-6Molecular imaging in infectious diseases
  • Track 14-7Molecular imaging in cardiovascular diseases
  • Track 14-8Nanotechnology in molecular Imaging
  • Track 14-9Techniques in molecular imaging

Molecular Plant Pathology is dedicated to the study of genetics of the plant species, the molecular aspects related to the interactions between plants and microbes and the molecular mechanisms which are responsible for the pathogenesis in plants. This type of study includes molecular approach for the research of plant diseases, their causing agents and plant-pathogen interactions. Research in this field has provided information on newest findings in molecular pathogenesis, epidemiology, genetic and evolution of plant pathogenic microorganisms. The experiments and methods involve molecular detection and characterization of plant pathogens together with investigations on molecular variability and phylogeny through the practical approach.

  • Track 15-1Molecular Plant Biology
  • Track 15-2Genetics of Plant Pathogenicity
  • Track 15-3Mechanism of Plant Microbe Interaction
  • Track 15-4Molecular techniques involved in Plant Pathology
  • Track 15-5Genetical basis of host recognition
  • Track 15-6Tumorigenesis in Plants

The modifications approaching to Pathology signify a marvellous opportunity for innovation and scientific encroachment. Implementation on market dynamics is a significant step which pathological laboratories should adopt to seize the prospects while reducing the difficulties. Growing research in different field is also creating a link for multidisciplinary work. This type of enhance the chances to attain the results more precisely using techniques related to different fields. In pathology also many disciplines are used altogether to perform tests and experiments for better results. Some of the disciplines are Anatomical Pathology, Cytopathology, Dermatopathology, Forensic Pathology, Histopathology, Neuropathology, Pulmonary Pathology, Surgical Pathology, Renal Pathology, Clinical Pathology and Hematopathology.

  • Track 16-1Hepatopathology
  • Track 16-2Anatomical pathology
  • Track 16-3Digital pathology
  • Track 16-4Gastrointestinal pathology
  • Track 16-5Hematopathology
  • Track 16-6Pulmonary pathology
  • Track 16-7Renal pathology and urinary track pathology
  • Track 16-8Surgical pathology
  • Track 16-9Speech Pathology
  • Track 16-10Veterinary pathology
  • Track 16-11Clinical pathology
  • Track 16-12Cytopathology
  • Track 16-13Microbial Pathology